1
|
Kratochvílová L, Mašek P, Neuberg M, Nováčková M, Toušek P, Sulženko J, Buděšínský T, Kočka ,AV. Might simplification of transcatheter aortic valve implantation reduce the burden on hospital resources? Eur Heart J Suppl 2022; 24:B28-B35. [PMID: 35370505 PMCID: PMC8971733 DOI: 10.1093/eurheartjsupp/suac009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Transcatheter aortic valve implantation (TAVI) varies considerably in terms of the procedural approach taken and the hospital length of stay (LoS); both directly affect the cost of care. Our coronary and standard cardiology unit aimed to simplify TAVI (and thus shorten the LoS) while maintaining safety. A shorter LoS would also reduce the burden on hospital resources and free up beds for other patients. Data on 214 consecutive patients undergoing TAVI at a single centre between April 2018 and March 2021 were retrospectively collected. A simplified protocol was implemented in January 2020; patients were stratified by whether they underwent TAVI before or after simplification. All procedural phases were simplified. For cost comparison purposes, the LoS was defined as the number of hospitalization days from admission to discharge. The total hospitalization cost was the sum of the direct and indirect (including reallocated overhead) costs. The LoS fell significantly (by 36%) after TAVI simplification. The times in the coronary care unit (CCU) and standard cardiac unit (SCU) also fell significantly (by 33% and 37% respectively). Patients in the simplified TAVI group were discharged, on average, 6 days after admission. The CCU costs decreased by 31% and the SCU costs by 39%. Transcatheter aortic valve implantation simplification did not compromise safety. Indeed, patients who underwent the simplified procedure seemed to develop fewer complications, especially bleeding. Transcatheter aortic valve implantation simplification significantly reduced the LoS and other costs without compromising patient safety.
Collapse
Affiliation(s)
- Lenka Kratochvílová
- Medtronic Czechia, Partner in the INTERCARDIS Project, Prosecká 66, Prague 19000, Czech Republic
| | - Petr Mašek
- Medtronic Czechia, Partner in the INTERCARDIS Project, Prosecká 66, Prague 19000, Czech Republic
| | - Marek Neuberg
- Medtronic Czechia, Partner in the INTERCARDIS Project, Prosecká 66, Prague 19000, Czech Republic
| | - Markéta Nováčková
- Department of Cardiology, University Hospital Královské Vinohrady and Third Faculty of Medicine, Charles University, Šrobárova 50, Prague 10, 100 34, Czech Republic
| | - Petr Toušek
- Department of Cardiology, University Hospital Královské Vinohrady and Third Faculty of Medicine, Charles University, Šrobárova 50, Prague 10, 100 34, Czech Republic
| | - Jakub Sulženko
- Department of Cardiology, University Hospital Královské Vinohrady and Third Faculty of Medicine, Charles University, Šrobárova 50, Prague 10, 100 34, Czech Republic
| | - Tomáš Buděšínský
- Department of Cardiology, University Hospital Královské Vinohrady and Third Faculty of Medicine, Charles University, Šrobárova 50, Prague 10, 100 34, Czech Republic
| | - , and Viktor Kočka
- Department of Cardiology, University Hospital Královské Vinohrady and Third Faculty of Medicine, Charles University, Šrobárova 50, Prague 10, 100 34, Czech Republic
| |
Collapse
|
2
|
Bohmann K, Burgdorf C, Zeus T, Joner M, Alvarez H, Berning KL, Schikowski M, Kasel AM, van Mark G, Deutsch C, Kurucova J, Thoenes M, Frank D, Wundram S, Bramlage P, Miller B, Veulemans V. The COORDINATE Pilot Study: Impact of a Transcatheter Aortic Valve Coordinator Program on Hospital and Patient Outcomes. J Clin Med 2022; 11:jcm11051205. [PMID: 35268296 PMCID: PMC8910867 DOI: 10.3390/jcm11051205] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/12/2022] [Revised: 02/15/2022] [Accepted: 02/19/2022] [Indexed: 12/03/2022] Open
Abstract
The transcatheter aortic valve implantation (TAVI) treatment pathway is complex, leading to procedure-related delays. Dedicated TAVI coordinators can improve pathway efficiency. COORDINATE was a pilot observational prospective registry at three German centers that enrolled consecutive elective patients with severe aortic stenosis undergoing TAVI to investigate the impact a TAVI coordinator program. Pathway parameters and clinical outcomes were assessed before (control group) and after TAVI coordinator program implementation (intervention phase). The number of repeated diagnostics remained unchanged after implementation. Patients with separate hospitalizations for screening and TAVI had long delays, which increased after implementation (65 days pre- vs. 103 days post-implementation); hospitalizations combining these were more efficient. The mean time between TAVI and hospital discharge remained constant. Nurse (p = 0.001) and medical technician (p = 0.008) working hours decreased. Patient satisfaction increased, and more consistent/intensive contact between patients and staff was reported. TAVI coordinators provided more post-TAVI support, including discharge management. No adverse effects on post-procedure or 30-day outcomes were seen. This pilot suggests that TAVI coordinator programs may improve aspects of the TAVI pathway, including post-TAVI care and patient satisfaction, without compromising safety. These findings will be further investigated in the BENCHMARK registry.
Collapse
Affiliation(s)
- Katja Bohmann
- Cardiothoracic Surgery Department, Heart and Vessel Center Bad Bevensen, 29549 Bad Bevensen, Germany; (K.B.); (M.S.)
| | - Christof Burgdorf
- Cardiology Department, Heart and Vessel Center Bad Bevensen, 29549 Bad Bevensen, Germany;
| | - Tobias Zeus
- Division of Cardiology, Pulmonology and Vascular Medicine, Medical Faculty, Heinrich Heine University, 40225 Düsseldorf, Germany; (T.Z.); (K.L.B.); (V.V.)
| | - Michael Joner
- German Heart Center Munich, 80636 Munich, Germany; (M.J.); (H.A.); (A.M.K.)
| | - Héctor Alvarez
- German Heart Center Munich, 80636 Munich, Germany; (M.J.); (H.A.); (A.M.K.)
| | - Kira Lisanne Berning
- Division of Cardiology, Pulmonology and Vascular Medicine, Medical Faculty, Heinrich Heine University, 40225 Düsseldorf, Germany; (T.Z.); (K.L.B.); (V.V.)
| | - Maren Schikowski
- Cardiothoracic Surgery Department, Heart and Vessel Center Bad Bevensen, 29549 Bad Bevensen, Germany; (K.B.); (M.S.)
| | - Albert Markus Kasel
- German Heart Center Munich, 80636 Munich, Germany; (M.J.); (H.A.); (A.M.K.)
- Cardiology Department, University Heart Centre, University Hospital Zurich, 8091 Zurich, Switzerland
| | - Gesine van Mark
- Institute for Pharmacology and Preventive Medicine, 49661 Cloppenburg, Germany; (G.v.M.); (C.D.); (P.B.)
| | - Cornelia Deutsch
- Institute for Pharmacology and Preventive Medicine, 49661 Cloppenburg, Germany; (G.v.M.); (C.D.); (P.B.)
| | | | | | - Derk Frank
- Internal Medicine III (Cardiology, Angiology and Intensive Care Medicine) Department, UKSH University Clinical Center Schleswig-Holstein, 24105 Kiel, Germany;
- German Centre for Cardiovascular Research, Partner Site Hamburg/Kiel/Lübeck, 24105 Kiel, Germany
- Correspondence: ; Tel.: +49-431-5002-2801
| | - Steffen Wundram
- Internal Medicine III (Cardiology, Angiology and Intensive Care Medicine) Department, UKSH University Clinical Center Schleswig-Holstein, 24105 Kiel, Germany;
- German Centre for Cardiovascular Research, Partner Site Hamburg/Kiel/Lübeck, 24105 Kiel, Germany
| | - Peter Bramlage
- Institute for Pharmacology and Preventive Medicine, 49661 Cloppenburg, Germany; (G.v.M.); (C.D.); (P.B.)
| | | | - Verena Veulemans
- Division of Cardiology, Pulmonology and Vascular Medicine, Medical Faculty, Heinrich Heine University, 40225 Düsseldorf, Germany; (T.Z.); (K.L.B.); (V.V.)
| |
Collapse
|